BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16670321)

  • 1. CD94/NKG2A expression is associated with proliferative potential of CD8 T cells during persistent polyoma virus infection.
    Byers AM; Andrews NP; Lukacher AE
    J Immunol; 2006 May; 176(10):6121-9. PubMed ID: 16670321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses.
    Moser JM; Gibbs J; Jensen PE; Lukacher AE
    Nat Immunol; 2002 Feb; 3(2):189-95. PubMed ID: 11812997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8(+) T cells.
    McMahon CW; Zajac AJ; Jamieson AM; Corral L; Hammer GE; Ahmed R; Raulet DH
    J Immunol; 2002 Aug; 169(3):1444-52. PubMed ID: 12133970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD94/NKG2 expression does not inhibit cytotoxic function of lymphocytic choriomeningitis virus-specific CD8+ T cells.
    Miller JD; Peters M; Oran AE; Beresford GW; Harrington L; Boss JM; Altman JD
    J Immunol; 2002 Jul; 169(2):693-701. PubMed ID: 12097371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
    Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KLRG1+NKG2A+ CD8 T cells mediate protection and participate in memory responses during γ-herpesvirus infection.
    Cush SS; Flaño E
    J Immunol; 2011 Apr; 186(7):4051-8. PubMed ID: 21346231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcineurin-dependent negative regulation of CD94/NKG2A expression on naive CD8+ T cells.
    Cho JH; Kim HO; Webster K; Palendira M; Hahm B; Kim KS; King C; Tangye SG; Sprent J
    Blood; 2011 Jul; 118(1):116-28. PubMed ID: 21540458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes.
    Arlettaz L; Villard J; de Rham C; Degermann S; Chapuis B; Huard B; Roosnek E
    Eur J Immunol; 2004 Dec; 34(12):3456-64. PubMed ID: 15517612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qa-1b and CD94-NKG2a interaction regulate cytolytic activity of herpes simplex virus-specific memory CD8+ T cells in the latently infected trigeminal ganglia.
    Suvas S; Azkur AK; Rouse BT
    J Immunol; 2006 Feb; 176(3):1703-11. PubMed ID: 16424200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway.
    Zeddou M; Greimers R; de Valensart N; Nayjib B; Tasken K; Boniver J; Moutschen M; Rahmouni S
    Biochem Pharmacol; 2005 Sep; 70(5):714-24. PubMed ID: 15978547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.
    Mingari MC; Ponte M; Bertone S; Schiavetti F; Vitale C; Bellomo R; Moretta A; Moretta L
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1172-7. PubMed ID: 9448304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells.
    Gunturi A; Berg RE; Crossley E; Murray S; Forman J
    Eur J Immunol; 2005 Mar; 35(3):766-75. PubMed ID: 15714583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of CD94/NKG2A inhibitory receptors on CD8+ T cells in HIV infection is more pronounced in subjects with detected viral load than in their aviraemic counterparts.
    Zeddou M; Rahmouni S; Vandamme A; Jacobs N; Frippiat F; Leonard P; Schaaf-Lafontaine N; Vaira D; Boniver J; Moutschen M
    Retrovirology; 2007 Oct; 4():72. PubMed ID: 17927817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late priming and variability of epitope-specific CD8+ T cell responses during a persistent virus infection.
    Kemball CC; Lee ED; Vezys V; Pearson TC; Larsen CP; Lukacher AE
    J Immunol; 2005 Jun; 174(12):7950-60. PubMed ID: 15944301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells.
    Byers AM; Kemball CC; Moser JM; Lukacher AE
    J Immunol; 2003 Jul; 171(1):17-21. PubMed ID: 12816977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection.
    Lukacher AE; Moser JM; Hadley A; Altman JD
    J Immunol; 1999 Sep; 163(6):3369-78. PubMed ID: 10477607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit.
    Tanaka J; Sugita J; Kato N; Toubai T; Ibata M; Shono Y; Ota S; Kondo T; Kobayashi T; Kobayashi M; Asaka M; Imamura M
    Exp Hematol; 2007 Oct; 35(10):1562-6. PubMed ID: 17681668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: engagement of NKG2A on CD8+ effector T cells limits immunopathology in influenza pneumonia.
    Zhou J; Matsuoka M; Cantor H; Homer R; Enelow RI
    J Immunol; 2008 Jan; 180(1):25-9. PubMed ID: 18096998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costimulation requirements for antiviral CD8+ T cells differ for acute and persistent phases of polyoma virus infection.
    Kemball CC; Lee ED; Szomolanyi-Tsuda E; Pearson TC; Larsen CP; Lukacher AE
    J Immunol; 2006 Feb; 176(3):1814-24. PubMed ID: 16424212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential induction of CD94 and NKG2 in CD4 helper T cells. A consequence of influenza virus infection and interferon-gamma?
    Graham CM; Christensen JR; Thomas DB
    Immunology; 2007 Jun; 121(2):238-47. PubMed ID: 17462078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.